Patent Baristas

At the BIO’s IPCC Conference today, attendees were treated to a look at pending cases that concern biotech. John Dragseth, a Partner at Fish & Richardson, gave an overview of the Mayo v. Prometheus case after filing a Petition for a Writ of Certiorari with the Supreme Court just hours earlier.  The Federal Circuit, reversing […]

The NIH Office of Biotechnology Activities (OBA) tries to promote science, safety, and ethics in biotechnology through advancement of knowledge, enhancement of public understanding, and development of public policies. The OBA manages the Secretary’s Advisory Committee on Genetics, Health, and Society (SACGHS), which advises the Secretary of Health and Human Services on the broad range […]

IAmBiotech, an online hub for showcasing the passion of the researchers, patients, farmers, and other innovators who are finding solutions through biotechnology, is looking for input from the biotech community. They have launched a survey to see how the biotech community is using social media to connect with one another online.  Do you think Facebook […]

Earlier, Amgen tried to stop the importation of recombinant human erythropoietin and derivatives (EPO) by filing a complaint with the International Trade Commission that is was a violation of Section 337 of the Tariff Act of 1930. Amgen charged that the imported EPO and the process by which it is produced in Europe are covered […]

In celebration of Earth Day, IAmBiotech and their “sister site” WhatCanBiotechDoForYou are spreading the word about the many ways biotechnology is helping save our environment.  The evolution of biotech has resulted in developments and new technologies that are helping to feed, fuel and heal the world.  Through sustainable agriculture and renewable fuels and products, the […]

In In re Kubin (08-1184), the US Court of Appeals for the Federal Circuit held that the US Patent and Trademark Office’s Board of Patent Appeals and Interferences was correct to hold claims as unpatentably obvious when applicants use “conventional techniques” to make an invention.  This is bad news not just for biotech but for […]

The U.S. Department of Health & Human Services is looking for input on a report looking at the effects of gene patents on patient access to genetic tests.  The Advisory Committee on Genetics, Health, and Society (SACGHS) is requesting public comments on a draft report to the Secretary of Health and Human Services, “Public Consultation […]

The Biotechnology Industry Organization (BIO) held a press conference today to provide an overview of the federal policy landscape and impact of the current financial market environment on the biotech industry. BIO President and CEO Jim Greenwood addressed the policies expected to be considered by the Obama Administration and the 111th Congress which will impact […]